Method of diagnosing blood clots using fibrin-binding proteins

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

530402, 530409, 530410, 530380, 930280, 424 9, A61K 4902, A61K 4300

Patent

active

052177050

ABSTRACT:
A fibrin-binding protein such as t-PA is labeled with a detectable substance, such as a radionuclide, and administered to a patient for diagnosis of blood clots and for monitoring the dissolution thereof during therapy. The detectable substance preferably is attached to t-PA through linkers which specifically bind to the portion of the t-PA protein responsible for enzymatic activity, thereby diminishing this activity while leaving the fibrin-binding property of the protein intact.

REFERENCES:
patent: 4318904 (1982-03-01), Shaw et al.
patent: 4381346 (1983-04-01), Huasin et al.
patent: 4416865 (1983-11-01), Rhodes et al.
patent: 4418052 (1983-11-01), Wong
patent: 4425319 (1984-01-01), Yokoyama et al.
patent: 4427646 (1984-01-01), Olexa et al.
patent: 4663146 (1987-05-01), Morser et al.
patent: 4741900 (1988-05-01), Alvarez et al.
patent: 4741903 (1988-05-01), Smith
patent: 4913891 (1990-04-01), Fowler et al.
Baker et al., European Journal of Nuclear Medicine (1985) 10:155-159.
Kettner and Shaw, Thrombosis Research 14; 969-973.
Kettner and Shaw, Methods in Enzymology, vol. 80, [63] 826-842.
Kettner and Shaw, Biochemistry, vol. 17, No. 22, 1978.
Collen et al., Leuven, Belgium, and Upton, N.Y., "In Vivo Studies of a Synthetic Inhibitor of Thrombin", J. Lab. Clin. Med., Jan. 1982.
Hnatowich et al., Eur. J. Nucl. Med. (1987) 13:467-473, "Characterization of indium-111 labeled recombinant tissue plasminogen activator for the imaging of thrombi".
International Search Report in the International (PCT) patent application that corresponds to U.S. Ser. No. 07/247.973.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Method of diagnosing blood clots using fibrin-binding proteins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of diagnosing blood clots using fibrin-binding proteins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of diagnosing blood clots using fibrin-binding proteins will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1932188

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.